Frances Rena Bahjat

Frances Rena Bahjat, PhD has a diverse work experience in the field of pharmaceutical research and development. They most recently held a position as the VP Discovery Biology and Pharmacology at Xencor starting in 2021. Prior to that, they served as the Vice President of Discovery Research at Apexigen from 2018 to 2020. From 2015 to 2018, they worked as the Senior Director of ImmunoOncology Discovery Preclinical Pharmacology and In vivo Antibody Discovery at Bristol-Myers Squibb. Between 2014 and 2015, they worked as a Preclinical Drug Development Consultant at Preclinical Development Consulting. They also held the positions of Research Assistant Professor at OHSU from 2009 to 2015, Senior Director of Pharmacology Research & Development at Oncovir from 2012 to 2014, Associate Director of Pharmacology R&D at Rigel from 2005 to 2008, Consultant Sr. Research Scientist at Corgentech in 2004, Research Scientist II at Nuvelo in 2004, and Research Scientist I at Nereus Pharmaceuticals from 2002 to 2004.

Frances Rena Bahjat, PhD completed their education history as follows:

From 1987 to 1991, they attended Oologah High School.

From 1993 to 1994, they attended Indiana University South Bend, pursuing studies in Biology (degree information not provided).

Frances Rena then enrolled at Benedictine University from 1995 to 1997, where they graduated magna cum laude with a Bachelor of Science degree in Biology.

Finally, from 1998 to 2002, Frances Rena Bahjat, PhD pursued their doctoral studies at the University of Florida College of Medicine, specializing in Biomedical Sciences with a focus in Immunology/Surgery. Frances Rena successfully obtained their PhD degree during this period.